Register Now

Book your Hotel Now

Contact Us


WFIRM's Alumni Reception
Date: Monday, December 4, 2017
Time: 6:00 PM-7:30 PM
Location: 213 CD in the Charlotte Convention Center
501 South College Street, Charlotte, NC 28202

Thematic Working Interest Groups (TWIGs)

Organizational Meetings Information

Plenary Speakers Announced

Dr. Samuel Stupp

Dr. George V. Ludwig

Dr. Kiran Masunuru

Important Dates:

Promotional Material:

Call for Abstracts Announcements: 4:3 | Widescreen


2017 Sponsors:


Burroughs Wellcome Fund


Wake Forest Institute for Regenerative Medicine (WFIRM)



McGowan Institute of Regenerative Medicine at the University of Pittsburgh (MIRM)

PeproTech, Inc.

Tissue Source, LLC

Business Plan Competition Sponsor

BioLife Solutions

Pre-Conference Workshop Sponsor - Imaging and Assessment of Engineered Tissues



O2M Technologies


2017 Exhibitors:

Advanced BioMatrix

Advanced Solutions Life Sciences


American Society of Transplantation

Aptus Bioreactors

Aspect Biosystems Ltd.

Biomomentum Inc.

BioSpherix Medical


CellScale Biomaterials Testing

Evonik Corporation

Flexcell International Corporation

The Geneva Foundation


International Institute for the Advancement of Medicine / IIAM

IOP Publishing

JPK Instruments AG

Kuraray Co. Ltd

LifeCore Biomedical

Mary Ann Liebert, Inc.

McGowan Institute for Regnerative Medicine at the Univeristy of Pittsburgh


Moor Instruments, Inc.

Nanoscience Instruments

NanoScribe GmbH

Nitta Gelatin

North Carolina Biotech Center

PeproTech Inc.

Perimed Inc.

Rees Scientific

Rheolution Inc.


SERVA Electrophoresis GmbH

STEMCELL Technologies Inc.

Tissue Source, LLC


University of Alberta / Banff Foundation for Allograft Pathology

Wake Forest Institute for Regenerative Medicine


Organized By:

TERMIS-AM Meeting is organized by the
Tissue Engineering & Regenerative Medicine International Society.

Pre-Conference Workshops

All workshops are being held Sunday, December 3, 2017.


Tools for Imaging and Assessment of Engineered Tissues
9:30 AM – 2:30 PM

Session Sponsored:

Description: There is a significant need for the development and application of novel imaging and assessment technologies for analysis of engineered tissues and biomaterials. Researchers often rely on microscopy of histological and immunohistochemical stained samples.  However, a broad range of tools are currently available and new methodologies are continually under development that provide TERMIS with new insights into the performance of their tissue engineering strategies. The goal of the workshop is to provide TERMIS engineers and scientist with information about tools available for analysis and imaging of engineered tissues. The first half of the workshop will involve presentations from industry representatives describing the capabilities of their technologies and the potential for use in TERM. The afternoon session will involve speakers developing and applying new tools that could enhance TERM research programs. The workshop will inform researchers of new tools but also engage researchers from outside the field to new applications for their techniques.

Session Chairs
Eric Brey
Heinz Redl

Academic Speakers

Mark Anastasio, Ph.D, Washington University in St. Louis
Eric Brey, Ph.D., University of Texas at San Antonio
Anjelica Gonzalez, Ph.D., Yale University
Marc Raphael, Ph.D., Naval Research Laboratory
Heinz Redl, Ph.D., Austrian Cluster for Tissue Regeneration

Industry Speakers

Alyssa Appel , Perimed Inc
Mrignayani Kotecha, Ph.D., O2M Technologies, LLC
TBD, Molecubes

Women in Science - Translational Development of TERM Women in Tissue Engineering and Regenerative Medicine Luncheon
11:00 AM – 2:30 PM
Workshop Co-Chairs:
Shannon Dahl (Humacyte): TBA  
Pamela Yelick (Tufts University): TBA
Evelyn Yim (University of Waterloo): Examples of academic-industry partnership funding opportunity in Canada

Workshop Speakers: 
Claudia Zylberberg (Akron Biotech): Examples of successful partnership
Nicolynn Davis (MilliporeSigma):  Academic industry partnership from MilleporeSigma perspective
Tracy Criswell (Wake Forest): Partnering with Industry: My Experience as an Academic Researcher
Kisten Cranpnell (BD Bioscience): Career path insights

Invited discussants and speakers: The panel will consist of members from TERM industries, TERM entrepreneurs, academic institutions with partnership with TERM industries and start-ups. 

TERMIS-AM 2017 will be hosted in North Carolina, one of the hubs for TERM industry.  In the last 3 decades, TERM research areas have undergone much advancement and groundbreaking research development.  TERM products have been marketed and a lot more are now reaching the clinical trial stage. Meanwhile, research funding agencies around the globe are promoting academic-industry partnership by providing industry collaborative funding, which further fosters partnership between academic institutions and TERM industries.

Women in TERM luncheon at TERMIS-AM 2017 is organized for women who are keen to learn about the opportunities and development of TERM industry as well as research partnership with TERM industry.  We aim to discuss:

Each panelist will be given 10 minutes to share their experiences and the remaining time will be allocated for active discussions and questions from the audience.  Audience members will also be given the opportunity to network with the speakers and their peers at the luncheon.

The Great Funding Chase: Strategies to fund academic or entrepreneurial research
1:00 PM – 3:30 PM

This pre-conference workshop focuses on the understanding and development of strategies to fund academic or entrepreneurial research along with strategies and soft skills enhancement with emphasis on communication and presentation skills. Whether students and trainees remain in an academic track or transition to entrepreneurial ventures, understanding the intricacies of different funding pathways and being able to successfully achieve positive outcomes are essential skills for career progression and success.

Phase I:  The 4 Funding Pathways
This section will discuss how to pick the right funding sources across the four major funding pathways and how to prepare a convincing proposal. 1) Grants; 2) Corporate sponsored research; 3) Philanthropy and 4) Venture/Angle Funding.
Speaker:  Doris A. Taylor, PhD

Phase II:  Understanding the process and what drives success: Aligning your approach with the goals and perspectives of your funding partners.
This section will address how the general process works across the FOUR pathways, elaborating on common pitfalls and highlighting success strategies. 
Speakers: Graca Almeida-Porada, MD, PhD, Todd McAllister, PhD, and Genevra Kelly, MPH

Phase III:   Success: Crafting your presentation to maximize results.
Once you have determined your best strategic approach, this session will focus on how to package your story to resonate with your audience.
Speakers:  Graca Almeida-Porada, MD, PhD, Todd McAllister, PhD, and Genevra Kelly, MPH

Cell and Tissue Manufacturing Innovation
1:00 PM – 4:00 PM
This pre-conference workshop entitled, “Cell and Tissue              Manufacturing Innovation” will provide a comprehensive overview of the current stage of manufacturing in tissue engineering and regenerative medicine. Diverse stakeholders and perspectives will be           presented that cover academic translational programs, development of standards for regenerative medicine manufacturing, industry perspectives, and government initiatives. The US Federal Government has been supporting Tissue Engineering and Regenerative Medicine for almost three decades, currently at a robust level of $1B per year where the Multi-Agency Tissue Engineering Sciences (MATES) working group provides a long-standing coordination mechanism for these efforts. The session will conclude with a round table discussion from these diverse stakeholders to          summarize the key developments and challenges in this important area of cell and tissue manufacturing.




Josh Hunsberger, Martha Lundberg, Richard McFarland – Co-chairs



Academic Translational Programs: Gearing up for Manufacturing
Julie Allickson, Director, Translational Research, Wake Forest School of Medicine



Developing Standards for Regenerative Medicine Manufacturing
Carl Simon, Project Leader, National Institute of Standards and Technology



Developing ISO Standards for Ancillary Materials
Claudia Zylberberg, CEO, Akron Biotech



Industry Perspectives on Manufacturing Challenges
Jon Rowley, Founder and Chief Technical Officer, RoosterBio, Inc.



Body-on-a-chip and Personalized Medicine
Tom Shupe, Assistant Professor, Wake Forest Institute for Regenerative Medicine






Government Manufacturing Programs
Lester Martinez-Lopez, Major General (RET), U.S. Army, and Chairman, Medical Technology Enterprise Consortium



21st Cures Act Bill and Implementation
Martha  S. Lundberg, NHLBI Program Director for Amy Patterson, Director, NHLBI Scientific Research Program, Policy, and Strategic Initiatives, National Institutes of Health



National Academies of Science, Engineering, and Medicine’s Forum on  Regenerative Medicine
Sarah Beachy, Senior Program Officer and Project Director, National Academy of Sciences, Engineering, and Medicine



Round Table Discussion